e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Sarcoidosis: various aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of CRP as the activity marker during the course of sarcoidosis
J. Videnovic-Ivanov, V. Vucinic, S. Filipovic, V. Zugic, J. Stojsic (Belgrade, Serbia And Montenegro)
Source:
Annual Congress 2007 - Sarcoidosis: various aspects
Session:
Sarcoidosis: various aspects
Session type:
Thematic Poster Session
Number:
794
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Videnovic-Ivanov, V. Vucinic, S. Filipovic, V. Zugic, J. Stojsic (Belgrade, Serbia And Montenegro). The role of CRP as the activity marker during the course of sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 794
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
The importance of inflammatory markers in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role
Source: Eur Respir J 2003; 22: Suppl. 45, 77s
Year: 2003
The serum levels of endothelin (ET-1); an activation marker and prognostic indicator in sarcoidosis?
Source: Eur Respir J 2005; 26: Suppl. 49, 80s
Year: 2005
Relationship between macrophage inflammatory protein-3β(MIP-3β) levels and clinical course of sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Year: 2002
The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
BALF TNFα level in relation to inflammatory status and phenotype of sarcoidosis
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
Serum biomarkers in SSc-ILD: association with presence, severity and prognosis
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Is YKL-40 a prognostic marker in sarcoidosis?
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Serum interleukin 18 as a monitoring marker of long clinical course of pulmonary sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 711s
Year: 2004
The role of systemic markers of inflammation in bronchiectasis.
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017
The role of serum cathepsin S levels in sarcoidosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Hepatic function markers in COPD as a systemic implication of the disease
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Frequently used inflammation markers and their role in monitoring tuberculosis treatment
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level
Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept